Truist Financial Increases Phreesia (NYSE:PHR) Price Target to $34.00

Phreesia (NYSE:PHR) had its target price lifted by analysts at Truist Financial from $31.00 to $34.00 in a research report issued on Wednesday,Benzinga reports. The brokerage presently has a “buy” rating on the stock. Truist Financial’s price target suggests a potential upside of 40.79% from the company’s current price.

PHR has been the topic of a number of other reports. DA Davidson reissued a “buy” rating and set a $32.00 price objective on shares of Phreesia in a report on Thursday, September 5th. Robert W. Baird cut their price objective on shares of Phreesia from $34.00 to $30.00 and set an “outperform” rating for the company in a research note on Wednesday. Royal Bank of Canada restated a “sector perform” rating and set a $23.00 price target on shares of Phreesia in a research report on Friday, September 27th. JPMorgan Chase & Co. boosted their price objective on Phreesia from $27.00 to $28.00 and gave the company an “overweight” rating in a research report on Monday, September 9th. Finally, Canaccord Genuity Group reiterated a “buy” rating and set a $34.00 price target on shares of Phreesia in a report on Thursday, September 5th. One research analyst has rated the stock with a hold rating and eleven have given a buy rating to the company. According to data from MarketBeat, Phreesia presently has a consensus rating of “Moderate Buy” and a consensus target price of $29.33.

Phreesia Stock Performance

Shares of PHR stock opened at $24.15 on Wednesday. The firm’s 50-day simple moving average is $20.26 and its two-hundred day simple moving average is $21.75. The company has a debt-to-equity ratio of 0.03, a quick ratio of 1.77 and a current ratio of 1.77. Phreesia has a 52 week low of $17.07 and a 52 week high of $29.16. The firm has a market cap of $1.40 billion, a price-to-earnings ratio of -13.42 and a beta of 0.98.

Phreesia (NYSE:PHR) last issued its earnings results on Monday, December 9th. The company reported ($0.25) earnings per share (EPS) for the quarter, beating analysts’ consensus estimates of ($0.29) by $0.04. Phreesia had a negative net margin of 25.73% and a negative return on equity of 39.34%. The business had revenue of $106.80 million for the quarter, compared to analysts’ expectations of $106.33 million. The business’s revenue for the quarter was up 16.6% compared to the same quarter last year. During the same quarter in the previous year, the firm posted ($0.58) EPS. As a group, equities analysts forecast that Phreesia will post -1.23 earnings per share for the current year.

Insider Activity

In related news, SVP Amy Beth Vanduyn sold 25,447 shares of the stock in a transaction dated Tuesday, December 3rd. The stock was sold at an average price of $20.93, for a total transaction of $532,605.71. Following the completion of the sale, the senior vice president now owns 93,470 shares in the company, valued at approximately $1,956,327.10. This trade represents a 21.40 % decrease in their ownership of the stock. The transaction was disclosed in a document filed with the SEC, which can be accessed through this hyperlink. Also, insider Yvonne Hui sold 2,791 shares of the business’s stock in a transaction on Tuesday, October 15th. The stock was sold at an average price of $20.92, for a total transaction of $58,387.72. Following the completion of the transaction, the insider now directly owns 27,228 shares in the company, valued at $569,609.76. This trade represents a 9.30 % decrease in their position. The disclosure for this sale can be found here. Insiders have sold a total of 53,569 shares of company stock worth $1,123,014 over the last 90 days. 5.80% of the stock is currently owned by insiders.

Institutional Trading of Phreesia

Large investors have recently made changes to their positions in the business. Champlain Investment Partners LLC lifted its holdings in Phreesia by 4.1% during the 3rd quarter. Champlain Investment Partners LLC now owns 2,503,837 shares of the company’s stock valued at $57,062,000 after buying an additional 97,847 shares in the last quarter. Franklin Resources Inc. raised its stake in shares of Phreesia by 3.0% during the third quarter. Franklin Resources Inc. now owns 1,497,631 shares of the company’s stock valued at $31,495,000 after acquiring an additional 42,973 shares in the last quarter. State Street Corp boosted its holdings in shares of Phreesia by 7.1% in the third quarter. State Street Corp now owns 1,327,586 shares of the company’s stock valued at $30,256,000 after purchasing an additional 88,517 shares during the period. Geode Capital Management LLC grew its stake in Phreesia by 4.7% in the third quarter. Geode Capital Management LLC now owns 1,245,797 shares of the company’s stock worth $28,397,000 after purchasing an additional 55,934 shares in the last quarter. Finally, TimesSquare Capital Management LLC increased its holdings in Phreesia by 2.3% during the 3rd quarter. TimesSquare Capital Management LLC now owns 868,409 shares of the company’s stock worth $19,791,000 after purchasing an additional 19,395 shares during the period. 92.10% of the stock is currently owned by institutional investors.

Phreesia Company Profile

Phreesia, Inc provides an integrated SaaS-based software and payment platform for the healthcare industry in the United States and Canada. The company offers access solutions that offers appointment scheduling system for online appointments, reminders, and referral tracking management; registration solution to automate patient self-registration; revenue cycle solution, which offer insurance-verification processes, point-of-sale payments applications, post-visit payment collection, and flexible payment options; and network connect solution to deliver clinically relevant content to patients.